HomeNewsWorldOmicron: Australia finds new strain that is hard to detect through PCR testing

Omicron: Australia finds new strain that is hard to detect through PCR testing

The new lineage has about half the gene variations of the original and cannot be detected with typical screening, Queenland's acting chief health officer Peter Aitken has said

December 09, 2021 / 10:42 IST
Story continues below Advertisement
Representational image (Source: Reuters)
Representational image (Source: Reuters)

Amid a global uptick in the cases of the recently detected Omicron coronavirus variant, Australia has reported a new lineage of the strain that is harder to detect with "typical screening".

"Queensland state found the new omicron lineage in an inbound traveller from South Africa. The new lineage has about half the gene variations of the original and cannot be detected with typical screening," the state's acting chief health officer Peter Aitken was quoted as saying by Bloomberg.

Story continues below Advertisement

Also read | Omicron could spread faster but it''s still not certain: WHO

According to Aitken, the new lineage has enough markers to be classified as Omicron but not enough is known about severity and vaccine effectiveness.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show